Triazolopyridines for the treatment of thrombosis disorders

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) C07D 211/34 (2006.01) C07D 221/00 (2006.01) C07D 249/00 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2338654

The invention is directed to novel triazolopyridine derivatives which are useful as antagonists of GPIIb/IIIa. Pharmaceutical compositions comprising the triazolopyridine derivatives of the present invention, methods of treating conditions mediated by GPIIb/IIIa (e.g., methods for treating platelet- mediated thrombotic disorders) along with processes for making the compounds and novel intermediates are also disclosed.

L'invention concerne de nouveaux dérivés de triazolopyridine utilisés comme antagonistes de GPIIb/IIIa. L'invention concerne également des compositions pharmaceutiques renfermant ces dérivés de triazolopyridine, des méthodes de traitement des états ayant pour origine GPIIb/IIIa (par exemple des méthodes destinées à traiter les dysfonctionnements thrombotiques d'origine plaquettaire), et enfin des processus de fabrication de composés et de nouveaux intermédiaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triazolopyridines for the treatment of thrombosis disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolopyridines for the treatment of thrombosis disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyridines for the treatment of thrombosis disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1445188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.